BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36637582)

  • 1. The non-invasive diagnosis of colorectal cancer via a SOX9-based gene panel.
    Xue VW; Ng SSM; Tsang HF; Wong HT; Leung WW; Wong YN; Wong YKE; Yu ACS; Yim AKY; Cho WCS; Tai WCS; Wong SCC
    Clin Exp Med; 2023 Oct; 23(6):2421-2432. PubMed ID: 36637582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
    Zhang H; Dong S; Feng J
    J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX9-activated FARSA-AS1 predetermines cell growth, stemness, and metastasis in colorectal cancer through upregulating FARSA and SOX9.
    Zhou T; Wu L; Ma N; Tang F; Yu Z; Jiang Z; Li Y; Zong Z; Hu K
    Cell Death Dis; 2020 Dec; 11(12):1071. PubMed ID: 33318478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer.
    Panza A; Votino C; Gentile A; Valvano MR; Colangelo T; Pancione M; Micale L; Merla G; Andriulli A; Sabatino L; Vinciguerra M; Prattichizzo C; Mazzoccoli G; Colantuoni V; Piepoli A
    Biochim Biophys Acta; 2014 Jun; 1843(6):1225-36. PubMed ID: 24631504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX9, miR-495, miR-590-3p, and miR-320d were identified as chemoradiotherapy-sensitive genes and miRNAs in colorectal cancer patients based on a microarray dataset.
    Du B; Wang T; Yang X; Wang J; Shi X; Wang X; Wu D; Feng L; Chen L; Zhang W
    Neoplasma; 2019 Jan; 66(1):8-19. PubMed ID: 30509082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Enhancer-Driven Stem Cell-Like Program Mediated by SOX9 Blocks Intestinal Differentiation in Colorectal Cancer.
    Liang X; Duronio GN; Yang Y; Bala P; Hebbar P; Spisak S; Sahgal P; Singh H; Zhang Y; Xie Y; Cejas P; Long HW; Bass AJ; Sethi NS
    Gastroenterology; 2022 Jan; 162(1):209-222. PubMed ID: 34571027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer.
    Panza A; Pazienza V; Ripoli M; Benegiamo G; Gentile A; Valvano MR; Augello B; Merla G; Prattichizzo C; Tavano F; Ranieri E; di Sebastiano P; Vinciguerra M; Andriulli A; Mazzoccoli G; Piepoli A
    Biochim Biophys Acta; 2013 Aug; 1833(8):1853-65. PubMed ID: 23583560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZRANB1 enhances stem-cell-like features and accelerates tumor progression by regulating Sox9-mediated USP22/Wnt/β-catenin pathway in colorectal cancer.
    Miao D; Wang Y; Jia Y; Tong J; Jiang S; Liu L
    Cell Signal; 2022 Feb; 90():110200. PubMed ID: 34798260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC00839 promotes colorectal cancer progression by recruiting RUVBL1/Tip60 complexes to activate NRF1.
    Liu X; Chen J; Zhang S; Liu X; Long X; Lan J; Zhou M; Zheng L; Zhou J
    EMBO Rep; 2022 Sep; 23(9):e54128. PubMed ID: 35876654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt/ß-catenin signaling.
    Prévostel C; Rammah-Bouazza C; Trauchessec H; Canterel-Thouennon L; Busson M; Ychou M; Blache P
    Oncotarget; 2016 Dec; 7(50):82228-82243. PubMed ID: 27429045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EIF3D promotes resistance to 5-fluorouracil in colorectal cancer through upregulating RUVBL1.
    Li C; Lu K; Yang C; Du W; Liang Z
    J Clin Lab Anal; 2023 Jan; 37(2):e24825. PubMed ID: 36592991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive Potential Circulating mRNA Markers for Colorectal Adenoma Using Targeted Sequencing.
    Xue VW; Cheung MT; Chan PT; Luk LLY; Lee VH; Au TC; Yu AC; Cho WCS; Tsang HFA; Chan AK; Wong SCC
    Sci Rep; 2019 Sep; 9(1):12943. PubMed ID: 31506480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
    Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
    Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
    Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
    Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sox9 mediated transcriptional activation of FOXK2 is critical for colorectal cancer cells proliferation.
    Qian Y; Xia S; Feng Z
    Biochem Biophys Res Commun; 2017 Jan; 483(1):475-481. PubMed ID: 28007600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA LINC00963 promotes proliferation and migration through the miR-124-3p/FZD4 pathway in colorectal cancer.
    Zheng K; Zhang TK
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7634-7644. PubMed ID: 32744689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent, truncating SOX9 mutations are associated with SOX9 overexpression, KRAS mutation, and TP53 wild type status in colorectal carcinoma.
    Javier BM; Yaeger R; Wang L; Sanchez-Vega F; Zehir A; Middha S; Sadowska J; Vakiani E; Shia J; Klimstra D; Ladanyi M; Iacobuzio-Donahue CA; Hechtman JF
    Oncotarget; 2016 Aug; 7(32):50875-50882. PubMed ID: 27248473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Circulating mRNA Profile for the Non-Invasive Diagnosis of Colorectal Cancer Using NanoString Technologies.
    Tsang HF; Pei XM; Wong YKE; Wong SCC
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible involvement of Wnt11 in colorectal cancer progression.
    Nishioka M; Ueno K; Hazama S; Okada T; Sakai K; Suehiro Y; Okayama N; Hirata H; Oka M; Imai K; Dahiya R; Hinoda Y
    Mol Carcinog; 2013 Mar; 52(3):207-17. PubMed ID: 22161723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.
    Wang Q; Huang Z; Ni S; Xiao X; Xu Q; Wang L; Huang D; Tan C; Sheng W; Du X
    PLoS One; 2012; 7(9):e44398. PubMed ID: 22970209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.